The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy-Reference-Cited by-同舟云学术

The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy

Published:2020-08-28 Issue:1 Volume:37 Page:78-82
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Nappi Rossella E.¹,Palacios Santiago²,Bruyniks Nico³,Particco Martire⁴,Panay Nick⁵,

Affiliation:

1. Research Centre for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy

2. Palacios Institute of Women’s Health, Madrid, Spain

3. BrInPhar Ltd, Iver Health, Buckinghamshire, UK

4. Shionogi Ltd, London, UK

5. Queen Charlotte's & Chelsea and Westminster Hospitals, Imperial College London, London, UK

Funder

Shionogi Ltd.

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2020.1813273